August 19, 2008 – St. Jude Medical Inc. said today it received European CE Mark approval and FDA clearance for the ...
Cardiac Resynchronization Therapy Devices (CRT)
Cardiac Resynchronization Therapy Devices (CRT) are cardiac electrophysiology (EP) systems that include a small electronic device that is surgically implanted into a pocket of skin to help both ventricles contract together. They are also called biventricular pacemakers. These systems can be used for pacing only, or can include a built-in defibrillator.
August 14, 2008 - This week doctors at the Texas Cardiac Arrhythmia Institute (TCAI) at St. David’s Medical Center ...
August 13, 2008
August 11, 2008 - The Sorin Group said last week the FDA approved the REPLY family of dual and single chamber pacemakers ...
August 10, 2008August 7, 2008 - St. Jude Medical Inc. today said it received regulatory approval, in addition to reimbursement ...
August 06, 2008July 25, 2008 - CryoCath Technologies Inc. said this week results previously presented from three European study centers ...
July 24, 2008Biotronik GmbH launched the Lumax 540 series, which includes implantable cardioverter defibrillators (ICDs) and a ...
June 24, 2008June 18, 2008 – Biotronik GmbH launched the Lumax 540 series, which includes implantable cardioverter ...
June 17, 2008
Medtronic has extended its line of CRT leads with Attain StarFix OTW (over-the-wire) lead (Model 4195), an active ...
June 16, 2008June 17, 2008 - The FDA has cleared Medtronic Attain StarFix OTW (over-the-wire) lead (Model 4195), an active fixation ...
June 16, 2008April 29, 2008 - Sorin Group Cardiac Rhythm Management completed the first implant in a clinical trial of its new ...
April 28, 2008April 24, 2008 - Boston Scientific Corp. completed enrollment in the Multicenter Automatic Defibrillator ...
April 23, 2008April 14, 2008 - Boston Scientific Corp. reported that the Japanese Ministry of Health, Labor and Welfare (MHLW) ...
April 13, 2008April 4, 2008 - Medtronic presented data at the ACC on its REVERSE (Resynchronization Reverses Remodeling in ...
April 03, 2008March 25, 2008 - Investigational agent KYNAPID (vernakalant hydrochloride) Injection converted short-duration atrial ...
March 24, 2008March 21, 2008 — The Drug Information Association (DIA) will host an educational forum in conjunction with the FDA and ...
March 20, 2008© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now